Outpace Bio
Company

Outpace Bio

Biotechnology Research 700 Dexter Ave N 70 employees
Employees
70
Contacts
4
Emails
4
Phones
3

Outpace Bio Overview

Headquarters
700 Dexter Ave N
Industry
Biotechnology Research
Employees
70
Founded
2020
Funding
144.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Outpace Bio

Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLast™), recruit a productive immune response in the tumor microenvironment (OutSmart™), and achieve the potency (OutSpacers™), specificity (Co-LOCKR™), and safety (EGFRopt™) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes. At Outpace Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse, and inclusive culture for all employees.

Outpace Bio Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

Outpace Bio Org Chart

Sample employees and titles
Name Title Contact
Karen Martin Director of Quality @ Outpace Bio
Email Phone
Eric Soller Cbo @ Outpace - Biotech Entrepreneur
Email
Alaa Halawa Investing in and Building
Email Phone
Marc Lajoie CEO at Outpace Bio
Email Phone

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile
Director 1 profile

Compare Similar Companies to Outpace Bio